Dr. Scholl’s partnered with startup Wiivv on personalized 3D-printed shoe insoles that customers can order for home delivery through a smartphone app. Read more…
Bayer plans to sell its consumer brands, including Dr. Scholl’s and Coppertone, as the German company seeks to focus on higher-margin pharmaceuticals. Bayer in November also announced plans to cut 12,000 jobs and sell its animal-health business to regain investor trust, The Wall Street Journal reported. Bayer’s over-the-counter sales have fallen in the past few years as consumer health products face greater competition from Amazon and private-label brands at drugstores, Bloomberg reported. Bayer acquired Merck’s consumer health brands in 2014.